Biochemical changes associated with non-alcoholic fatty liver disease in response to berberine treatment: a systematic review and meta-analysis of clinical and preclinical research.
- 2025-08-29
- Systematic Review
- Frontiers in pharmacology 16
- Wenyu Zhu
- Lele Yang
- Yufan Dai
- Hanyang Wang
- Jiaxuan Zhou
- Lina Xia
- Tao Shen
- PubMed: 40949129
- DOI: 10.3389/fphar.2025.1460643
- High evidence
Clinically, berberine significantly reduced fasting blood glucose (FBG) levels, with an effect size of 0.53 (95% CI: 0.04-1.01).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes